Under some pathological conditions, GSK-3β activity is upregulated, exerting its adverse influence on cholinergic signaling increasingly and, at the same time, inducing phosphorylation events critical to the development of proteinopathies [61]. This evidence concerns the gene GSK3B and proteostasis deficiencies.